nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—IKBKB—Sulfasalazine—ankylosing spondylitis	0.18	0.452	CbGbCtD
Acetylsalicylic acid—migraine—Prednisone—ankylosing spondylitis	0.162	0.341	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Prednisone—ankylosing spondylitis	0.157	0.33	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.157	0.33	CpDpCtD
Acetylsalicylic acid—PTGS2—Triamcinolone—ankylosing spondylitis	0.0258	0.0648	CbGbCtD
Acetylsalicylic acid—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0258	0.0648	CbGbCtD
Acetylsalicylic acid—PTGS2—Betamethasone—ankylosing spondylitis	0.0221	0.0556	CbGbCtD
Acetylsalicylic acid—PTGS1—Sulfasalazine—ankylosing spondylitis	0.0218	0.0547	CbGbCtD
Acetylsalicylic acid—SLC22A7—Methotrexate—ankylosing spondylitis	0.018	0.0453	CbGbCtD
Acetylsalicylic acid—ALB—Prednisone—ankylosing spondylitis	0.013	0.0327	CbGbCtD
Acetylsalicylic acid—PTGS2—Dexamethasone—ankylosing spondylitis	0.0129	0.0323	CbGbCtD
Acetylsalicylic acid—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0112	0.0282	CbGbCtD
Acetylsalicylic acid—HSPA5—skeletal joint—ankylosing spondylitis	0.00843	0.356	CbGeAlD
Acetylsalicylic acid—CYP2C19—Prednisone—ankylosing spondylitis	0.00843	0.0212	CbGbCtD
Acetylsalicylic acid—SLC22A6—Methotrexate—ankylosing spondylitis	0.00766	0.0192	CbGbCtD
Acetylsalicylic acid—ABCB1—Betamethasone—ankylosing spondylitis	0.0073	0.0183	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisolone—ankylosing spondylitis	0.0072	0.0181	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisone—ankylosing spondylitis	0.0068	0.0171	CbGbCtD
Acetylsalicylic acid—ALB—Methotrexate—ankylosing spondylitis	0.00653	0.0164	CbGbCtD
Acetylsalicylic acid—CYP2C8—Dexamethasone—ankylosing spondylitis	0.00627	0.0158	CbGbCtD
Acetylsalicylic acid—HSPA5—cartilage tissue—ankylosing spondylitis	0.00567	0.24	CbGeAlD
Acetylsalicylic acid—CYP2C19—Dexamethasone—ankylosing spondylitis	0.00526	0.0132	CbGbCtD
Acetylsalicylic acid—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00438	0.011	CbGbCtD
Acetylsalicylic acid—ABCB1—Dexamethasone—ankylosing spondylitis	0.00425	0.0107	CbGbCtD
Acetylsalicylic acid—ABCB1—Methotrexate—ankylosing spondylitis	0.00341	0.00857	CbGbCtD
Acetylsalicylic acid—PTGS2—skeletal joint—ankylosing spondylitis	0.00169	0.0712	CbGeAlD
Acetylsalicylic acid—PTGS2—synovial membrane of synovial joint—ankylosing spondylitis	0.00128	0.0541	CbGeAlD
Acetylsalicylic acid—PTGS2—cartilage tissue—ankylosing spondylitis	0.00113	0.0479	CbGeAlD
Acetylsalicylic acid—TP53—tendon—ankylosing spondylitis	0.00101	0.0425	CbGeAlD
Acetylsalicylic acid—NFKBIA—tendon—ankylosing spondylitis	0.000989	0.0418	CbGeAlD
Acetylsalicylic acid—HSPA5—tendon—ankylosing spondylitis	0.000969	0.0409	CbGeAlD
Acetylsalicylic acid—Diabetic—Methylprednisolone—ankylosing spondylitis	0.000885	0.0294	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—tendon—ankylosing spondylitis	0.000825	0.0349	CbGeAlD
Acetylsalicylic acid—Diabetic—Dexamethasone—ankylosing spondylitis	0.000805	0.0267	CcSEcCtD
Acetylsalicylic acid—Diabetic—Betamethasone—ankylosing spondylitis	0.000805	0.0267	CcSEcCtD
Acetylsalicylic acid—Metabolic acidosis—Methylprednisolone—ankylosing spondylitis	0.000747	0.0248	CcSEcCtD
Acetylsalicylic acid—EDNRA—tendon—ankylosing spondylitis	0.000671	0.0284	CbGeAlD
Acetylsalicylic acid—IKBKB—tendon—ankylosing spondylitis	0.000609	0.0257	CbGeAlD
Acetylsalicylic acid—Gastric irritation—Prednisone—ankylosing spondylitis	0.000603	0.0201	CcSEcCtD
Acetylsalicylic acid—Diabetic—Methotrexate—ankylosing spondylitis	0.000586	0.0195	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Prednisolone—ankylosing spondylitis	0.000481	0.016	CcSEcCtD
Acetylsalicylic acid—Epigastric discomfort—Prednisone—ankylosing spondylitis	0.000445	0.0148	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Triamcinolone—ankylosing spondylitis	0.000443	0.0147	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Methylprednisolone—ankylosing spondylitis	0.000442	0.0147	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Dexamethasone—ankylosing spondylitis	0.000402	0.0134	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Betamethasone—ankylosing spondylitis	0.000402	0.0134	CcSEcCtD
Acetylsalicylic acid—TP53—Testosterone—Prednisolone—ankylosing spondylitis	0.000367	0.157	CbGdCrCtD
Acetylsalicylic acid—Peptic ulcer—Prednisone—ankylosing spondylitis	0.00035	0.0116	CcSEcCtD
Acetylsalicylic acid—Eruption—Methotrexate—ankylosing spondylitis	0.000318	0.0106	CcSEcCtD
Acetylsalicylic acid—Ulcer—Triamcinolone—ankylosing spondylitis	0.000313	0.0104	CcSEcCtD
Acetylsalicylic acid—Contusion—Dexamethasone—ankylosing spondylitis	0.000308	0.0102	CcSEcCtD
Acetylsalicylic acid—Contusion—Betamethasone—ankylosing spondylitis	0.000308	0.0102	CcSEcCtD
Acetylsalicylic acid—TP53—Danazol—Prednisone—ankylosing spondylitis	0.000305	0.131	CbGdCrCtD
Acetylsalicylic acid—IKBKB—IL1-mediated signaling events—IL1A—ankylosing spondylitis	0.0003	0.00434	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000298	0.0043	CbGpPWpGaD
Acetylsalicylic acid—Liver disorder—Methotrexate—ankylosing spondylitis	0.000287	0.00953	CcSEcCtD
Acetylsalicylic acid—Ulcer—Betamethasone—ankylosing spondylitis	0.000284	0.00944	CcSEcCtD
Acetylsalicylic acid—Ulcer—Dexamethasone—ankylosing spondylitis	0.000284	0.00944	CcSEcCtD
Acetylsalicylic acid—Haematemesis—Methotrexate—ankylosing spondylitis	0.000281	0.00935	CcSEcCtD
Acetylsalicylic acid—TP53—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.000271	0.00391	CbGpPWpGaD
Acetylsalicylic acid—Diabetes mellitus—Prednisolone—ankylosing spondylitis	0.000269	0.00893	CcSEcCtD
Acetylsalicylic acid—Contusion—Prednisone—ankylosing spondylitis	0.000268	0.00891	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000265	0.113	CbGdCrCtD
Acetylsalicylic acid—IKBKB—Interleukin-1 signaling—IL1A—ankylosing spondylitis	0.000264	0.00381	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—ankylosing spondylitis	0.000262	0.00378	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000261	0.00377	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.00026	0.111	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.00026	0.111	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000254	0.109	CbGdCrCtD
Acetylsalicylic acid—Hepatotoxicity—Methotrexate—ankylosing spondylitis	0.000253	0.00841	CcSEcCtD
Acetylsalicylic acid—Ulcer—Prednisone—ankylosing spondylitis	0.000247	0.00822	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Triamcinolone—ankylosing spondylitis	0.000247	0.00821	CcSEcCtD
Acetylsalicylic acid—TP53—Spinal Cord Injury—IL1A—ankylosing spondylitis	0.000247	0.00356	CbGpPWpGaD
Acetylsalicylic acid—Diabetes mellitus—Methylprednisolone—ankylosing spondylitis	0.000246	0.00819	CcSEcCtD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.000246	0.00355	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Senescence-Associated Secretory Phenotype (SASP)—IL1A—ankylosing spondylitis	0.000245	0.00354	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.000244	0.00353	CbGpPWpGaD
Acetylsalicylic acid—Vascular purpura—Triamcinolone—ankylosing spondylitis	0.00024	0.00798	CcSEcCtD
Acetylsalicylic acid—NFKBIA—MyD88:Mal cascade initiated on plasma membrane—TLR4—ankylosing spondylitis	0.00024	0.00347	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.000239	0.00345	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—IL23-mediated signaling events—TNF—ankylosing spondylitis	0.000239	0.00345	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Structural Pathway of Interleukin 1 (IL-1)—IL1A—ankylosing spondylitis	0.000232	0.00335	CbGpPWpGaD
Acetylsalicylic acid—TP53—Amyotrophic lateral sclerosis (ALS)—TNF—ankylosing spondylitis	0.000231	0.00334	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000231	0.00334	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—MyD88-independent cascade—TLR4—ankylosing spondylitis	0.00023	0.00333	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.000225	0.00325	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis Modulation and Signaling—TNFRSF1B—ankylosing spondylitis	0.000224	0.00324	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Class I MHC mediated antigen processing & presentation—HLA-B—ankylosing spondylitis	0.000224	0.00324	CbGpPWpGaD
Acetylsalicylic acid—Diabetes mellitus—Betamethasone—ankylosing spondylitis	0.000224	0.00745	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Dexamethasone—ankylosing spondylitis	0.000224	0.00745	CcSEcCtD
Acetylsalicylic acid—Purpura—Triamcinolone—ankylosing spondylitis	0.000223	0.00741	CcSEcCtD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.000222	0.00321	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.000222	0.0032	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000222	0.0032	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—TWEAK Signaling Pathway—TNF—ankylosing spondylitis	0.000216	0.00312	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MyD88:Mal cascade initiated on plasma membrane—TLR4—ankylosing spondylitis	0.000215	0.0031	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000213	0.00308	CbGpPWpGaD
Acetylsalicylic acid—SLC22A7—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000211	0.00304	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IL1R2—ankylosing spondylitis	0.000209	0.00302	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Class I MHC mediated antigen processing & presentation—HLA-A—ankylosing spondylitis	0.000208	0.003	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Activated TLR4 signalling—TLR4—ankylosing spondylitis	0.000207	0.00299	CbGpPWpGaD
Acetylsalicylic acid—Ulcer—Methotrexate—ankylosing spondylitis	0.000207	0.00687	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—MyD88-independent cascade—TLR4—ankylosing spondylitis	0.000206	0.00297	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—IL-1 signaling pathway—IL1A—ankylosing spondylitis	0.000205	0.00295	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—B Cell Activation—CD79A—ankylosing spondylitis	0.000204	0.00294	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—tendon—ankylosing spondylitis	0.000203	0.00857	CbGeAlD
Acetylsalicylic acid—IKBKB—TCR Signaling Pathway—IL17A—ankylosing spondylitis	0.000202	0.00291	CbGpPWpGaD
Acetylsalicylic acid—Respiratory failure—Methotrexate—ankylosing spondylitis	0.000199	0.00662	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—KIR3DL1—ankylosing spondylitis	0.000198	0.00286	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—ERAP1—ankylosing spondylitis	0.000198	0.00286	CbGpPWpGaD
Acetylsalicylic acid—TP53—Spinal Cord Injury—TLR4—ankylosing spondylitis	0.000198	0.00286	CbGpPWpGaD
Acetylsalicylic acid—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.000195	0.00649	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	0.000195	0.00281	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Ceramide signaling pathway—TNF—ankylosing spondylitis	0.000194	0.0028	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—tendon—ankylosing spondylitis	0.000194	0.00819	CbGeAlD
Acetylsalicylic acid—Melaena—Methotrexate—ankylosing spondylitis	0.000191	0.00635	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Prednisone—ankylosing spondylitis	0.00019	0.00631	CcSEcCtD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000188	0.00271	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000188	0.00271	CbGpPWpGaD
Acetylsalicylic acid—TP53—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000186	0.00269	CbGpPWpGaD
Acetylsalicylic acid—Influenza—Triamcinolone—ankylosing spondylitis	0.000186	0.00617	CcSEcCtD
Acetylsalicylic acid—Asthma—Triamcinolone—ankylosing spondylitis	0.000186	0.00617	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Activated TLR4 signalling—TLR4—ankylosing spondylitis	0.000185	0.00267	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000185	0.00266	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—CARD9—ankylosing spondylitis	0.000181	0.00262	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.00018	0.0026	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—CARD9—ankylosing spondylitis	0.000179	0.00258	CbGpPWpGaD
Acetylsalicylic acid—Coma—Methotrexate—ankylosing spondylitis	0.000179	0.00594	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.000177	0.0059	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.000177	0.0059	CcSEcCtD
Acetylsalicylic acid—EDNRA—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000177	0.00256	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—KIR3DL1—ankylosing spondylitis	0.000177	0.00256	CbGpPWpGaD
Acetylsalicylic acid—Purpura—Prednisone—ankylosing spondylitis	0.000176	0.00586	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000176	0.00254	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	0.000174	0.00252	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000174	0.00251	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—ANTXR2—ankylosing spondylitis	0.000173	0.0025	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cellular Senescence—IL1A—ankylosing spondylitis	0.000172	0.00248	CbGpPWpGaD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.00017	0.00564	CcSEcCtD
Acetylsalicylic acid—IKBKB—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.00017	0.00245	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000168	0.00243	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by Interleukins—IL1RN—ankylosing spondylitis	0.000166	0.00239	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.000163	0.00236	CbGpPWpGaD
Acetylsalicylic acid—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.000163	0.00542	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000162	0.0054	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000162	0.00537	CcSEcCtD
Acetylsalicylic acid—Polyuria—Methotrexate—ankylosing spondylitis	0.000162	0.00537	CcSEcCtD
Acetylsalicylic acid—IKBKB—Type II diabetes mellitus—TNF—ankylosing spondylitis	0.000161	0.00233	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—CARD9—ankylosing spondylitis	0.00016	0.00231	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.00016	0.0682	CbGdCrCtD
Acetylsalicylic acid—IKBKB—B Cell Receptor Signaling Pathway—CD79A—ankylosing spondylitis	0.000158	0.00229	CbGpPWpGaD
Acetylsalicylic acid—Sweating—Methylprednisolone—ankylosing spondylitis	0.000158	0.00526	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000157	0.0671	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000157	0.0671	CbGdCrCtD
Acetylsalicylic acid—IKBKB—EBV LMP1 signaling—TNF—ankylosing spondylitis	0.000155	0.00224	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Canonical NF-kappaB pathway—TNF—ankylosing spondylitis	0.000155	0.00224	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000155	0.00224	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular Senescence—IL1A—ankylosing spondylitis	0.000155	0.00224	CbGpPWpGaD
Acetylsalicylic acid—Hypokalaemia—Prednisone—ankylosing spondylitis	0.000155	0.00514	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000154	0.0656	CbGdCrCtD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000152	0.00219	CbGpPWpGaD
Acetylsalicylic acid—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000149	0.00497	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000149	0.00495	CcSEcCtD
Acetylsalicylic acid—PTGS1—Overview of nanoparticle effects—TNF—ankylosing spondylitis	0.000149	0.00215	CbGpPWpGaD
Acetylsalicylic acid—TP53—Folate Metabolism—TNF—ankylosing spondylitis	0.000149	0.00215	CbGpPWpGaD
Acetylsalicylic acid—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000149	0.00494	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000148	0.00493	CcSEcCtD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000148	0.00213	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000146	0.00211	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000146	0.00211	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000145	0.0021	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling events mediated by HDAC Class I—TNF—ankylosing spondylitis	0.000144	0.00207	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000143	0.00207	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000143	0.00207	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR Signaling Pathway—IL1A—ankylosing spondylitis	0.000138	0.00199	CbGpPWpGaD
Acetylsalicylic acid—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000136	0.00451	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000136	0.00451	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000135	0.00448	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000135	0.00448	CcSEcCtD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000132	0.00191	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cellular responses to stress—IL1A—ankylosing spondylitis	0.00013	0.00187	CbGpPWpGaD
Acetylsalicylic acid—TP53—Alzheimers Disease—TNF—ankylosing spondylitis	0.000129	0.00186	CbGpPWpGaD
Acetylsalicylic acid—Angioedema—Prednisolone—ankylosing spondylitis	0.000129	0.00427	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisolone—ankylosing spondylitis	0.000126	0.0042	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisolone—ankylosing spondylitis	0.000126	0.00419	CcSEcCtD
Acetylsalicylic acid—HSPA5—MAPK Signaling Pathway—TNF—ankylosing spondylitis	0.000124	0.00179	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Apoptosis—TNF—ankylosing spondylitis	0.000124	0.00179	CbGpPWpGaD
Acetylsalicylic acid—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000124	0.00411	CcSEcCtD
Acetylsalicylic acid—Asthma—Methotrexate—ankylosing spondylitis	0.000123	0.00408	CcSEcCtD
Acetylsalicylic acid—TP53—Apoptosis—TNF—ankylosing spondylitis	0.000123	0.00177	CbGpPWpGaD
Acetylsalicylic acid—Convulsion—Prednisolone—ankylosing spondylitis	0.000122	0.00405	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisolone—ankylosing spondylitis	0.000121	0.00404	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—IL1R2—ankylosing spondylitis	0.00012	0.00173	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by Interleukins—IL1A—ankylosing spondylitis	0.000119	0.00172	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Overview of nanoparticle effects—TNF—ankylosing spondylitis	0.000118	0.00171	CbGpPWpGaD
Acetylsalicylic acid—Angioedema—Triamcinolone—ankylosing spondylitis	0.000118	0.00393	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Prednisone—ankylosing spondylitis	0.000118	0.00392	CcSEcCtD
Acetylsalicylic acid—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000118	0.00392	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisone—ankylosing spondylitis	0.000117	0.0039	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000117	0.00169	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000117	0.00168	CbGpPWpGaD
Acetylsalicylic acid—Vertigo—Triamcinolone—ankylosing spondylitis	0.000116	0.00386	CcSEcCtD
Acetylsalicylic acid—Syncope—Triamcinolone—ankylosing spondylitis	0.000116	0.00386	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000116	0.00386	CcSEcCtD
Acetylsalicylic acid—Syncope—Methylprednisolone—ankylosing spondylitis	0.000116	0.00385	CcSEcCtD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000116	0.00167	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.000115	0.00167	CbGpPWpGaD
Acetylsalicylic acid—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000115	0.00382	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—HLA-C—ankylosing spondylitis	0.000114	0.00164	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—ERAP1—ankylosing spondylitis	0.000114	0.00164	CbGpPWpGaD
Acetylsalicylic acid—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000114	0.00378	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000113	0.00377	CcSEcCtD
Acetylsalicylic acid—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000113	0.00164	CbGpPWpGaD
Acetylsalicylic acid—Shock—Prednisolone—ankylosing spondylitis	0.000113	0.00376	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HLA-C—ankylosing spondylitis	0.000112	0.00162	CbGpPWpGaD
Acetylsalicylic acid—Convulsion—Triamcinolone—ankylosing spondylitis	0.000112	0.00373	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisolone—ankylosing spondylitis	0.000112	0.00373	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000112	0.00372	CcSEcCtD
Acetylsalicylic acid—Hypertension—Triamcinolone—ankylosing spondylitis	0.000112	0.00371	CcSEcCtD
Acetylsalicylic acid—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000111	0.0037	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000111	0.00369	CcSEcCtD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000111	0.0016	CbGpPWpGaD
Acetylsalicylic acid—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00011	0.00365	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Methotrexate—ankylosing spondylitis	0.000109	0.00363	CcSEcCtD
Acetylsalicylic acid—Flushing—Prednisone—ankylosing spondylitis	0.000109	0.00362	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000108	0.00156	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL1R2—ankylosing spondylitis	0.000107	0.00155	CbGpPWpGaD
Acetylsalicylic acid—Angioedema—Dexamethasone—ankylosing spondylitis	0.000107	0.00357	CcSEcCtD
Acetylsalicylic acid—Angioedema—Betamethasone—ankylosing spondylitis	0.000107	0.00357	CcSEcCtD
Acetylsalicylic acid—IKBKB—MyD88:Mal cascade initiated on plasma membrane—TLR4—ankylosing spondylitis	0.000107	0.00154	CbGpPWpGaD
Acetylsalicylic acid—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000106	0.00353	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000106	0.00153	CbGpPWpGaD
Acetylsalicylic acid—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000106	0.00351	CcSEcCtD
Acetylsalicylic acid—Vertigo—Dexamethasone—ankylosing spondylitis	0.000105	0.00351	CcSEcCtD
Acetylsalicylic acid—Vertigo—Betamethasone—ankylosing spondylitis	0.000105	0.00351	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000105	0.0035	CcSEcCtD
Acetylsalicylic acid—Syncope—Betamethasone—ankylosing spondylitis	0.000105	0.0035	CcSEcCtD
Acetylsalicylic acid—Syncope—Dexamethasone—ankylosing spondylitis	0.000105	0.0035	CcSEcCtD
Acetylsalicylic acid—Sweating—Methotrexate—ankylosing spondylitis	0.000105	0.00348	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—CARD9—ankylosing spondylitis	0.000104	0.0015	CbGpPWpGaD
Acetylsalicylic acid—Shock—Triamcinolone—ankylosing spondylitis	0.000104	0.00345	CcSEcCtD
Acetylsalicylic acid—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000104	0.0015	CbGpPWpGaD
Acetylsalicylic acid—Shock—Methylprednisolone—ankylosing spondylitis	0.000104	0.00345	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000103	0.00343	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000103	0.00343	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000103	0.00343	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000103	0.00342	CcSEcCtD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000103	0.00148	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MyD88-independent cascade—TLR4—ankylosing spondylitis	0.000102	0.00148	CbGpPWpGaD
Acetylsalicylic acid—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000102	0.00339	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Disease—B3GNT2—ankylosing spondylitis	0.000102	0.00147	CbGpPWpGaD
Acetylsalicylic acid—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000102	0.00339	CcSEcCtD
Acetylsalicylic acid—Convulsion—Dexamethasone—ankylosing spondylitis	0.000102	0.00338	CcSEcCtD
Acetylsalicylic acid—Convulsion—Betamethasone—ankylosing spondylitis	0.000102	0.00338	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Immune System—ERAP1—ankylosing spondylitis	0.000102	0.00147	CbGpPWpGaD
Acetylsalicylic acid—Hypertension—Betamethasone—ankylosing spondylitis	0.000101	0.00337	CcSEcCtD
Acetylsalicylic acid—Hypertension—Dexamethasone—ankylosing spondylitis	0.000101	0.00337	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HLA-C—ankylosing spondylitis	0.0001	0.00145	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.0001	0.00144	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IL1RN—ankylosing spondylitis	9.88e-05	0.00143	CbGpPWpGaD
Acetylsalicylic acid—Haemoglobin—Methotrexate—ankylosing spondylitis	9.87e-05	0.00328	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methotrexate—ankylosing spondylitis	9.82e-05	0.00326	CcSEcCtD
Acetylsalicylic acid—PTGS1—Selenium Micronutrient Network—CRP—ankylosing spondylitis	9.66e-05	0.00139	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	9.64e-05	0.00139	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TWEAK Signaling Pathway—TNF—ankylosing spondylitis	9.6e-05	0.00139	CbGpPWpGaD
Acetylsalicylic acid—ALB—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	9.6e-05	0.00139	CbGpPWpGaD
Acetylsalicylic acid—Anaphylactic shock—Betamethasone—ankylosing spondylitis	9.58e-05	0.00318	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	9.58e-05	0.00318	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisolone—ankylosing spondylitis	9.46e-05	0.00315	CcSEcCtD
Acetylsalicylic acid—Anaemia—Prednisone—ankylosing spondylitis	9.45e-05	0.00314	CcSEcCtD
Acetylsalicylic acid—Shock—Dexamethasone—ankylosing spondylitis	9.43e-05	0.00313	CcSEcCtD
Acetylsalicylic acid—Shock—Betamethasone—ankylosing spondylitis	9.43e-05	0.00313	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Triamcinolone—ankylosing spondylitis	9.41e-05	0.00313	CcSEcCtD
Acetylsalicylic acid—Agitation—Prednisone—ankylosing spondylitis	9.4e-05	0.00312	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	9.38e-05	0.00312	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Betamethasone—ankylosing spondylitis	9.38e-05	0.00312	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Betamethasone—ankylosing spondylitis	9.35e-05	0.00311	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Dexamethasone—ankylosing spondylitis	9.35e-05	0.00311	CcSEcCtD
Acetylsalicylic acid—TP53—Spinal Cord Injury—TNF—ankylosing spondylitis	9.34e-05	0.00135	CbGpPWpGaD
Acetylsalicylic acid—Angioedema—Prednisone—ankylosing spondylitis	9.34e-05	0.00311	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Immune System—CARD9—ankylosing spondylitis	9.3e-05	0.00134	CbGpPWpGaD
Acetylsalicylic acid—Dyspepsia—Triamcinolone—ankylosing spondylitis	9.3e-05	0.00309	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methylprednisolone—ankylosing spondylitis	9.27e-05	0.00308	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	9.26e-05	0.00308	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Betamethasone—ankylosing spondylitis	9.26e-05	0.00308	CcSEcCtD
Acetylsalicylic acid—IKBKB—Activated TLR4 signalling—TLR4—ankylosing spondylitis	9.21e-05	0.00133	CbGpPWpGaD
Acetylsalicylic acid—Vertigo—Prednisone—ankylosing spondylitis	9.19e-05	0.00305	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisone—ankylosing spondylitis	9.17e-05	0.00305	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Methotrexate—ankylosing spondylitis	9.15e-05	0.00304	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisolone—ankylosing spondylitis	9.12e-05	0.00303	CcSEcCtD
Acetylsalicylic acid—IKBKB—B Cell Activation—CD79A—ankylosing spondylitis	9.06e-05	0.00131	CbGpPWpGaD
Acetylsalicylic acid—Loss of consciousness—Prednisone—ankylosing spondylitis	8.99e-05	0.00299	CcSEcCtD
Acetylsalicylic acid—IKBKB—TNF receptor signaling pathway —TNF—ankylosing spondylitis	8.93e-05	0.00129	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	8.9e-05	0.00128	CbGpPWpGaD
Acetylsalicylic acid—Convulsion—Prednisone—ankylosing spondylitis	8.86e-05	0.00294	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisone—ankylosing spondylitis	8.83e-05	0.00293	CcSEcCtD
Acetylsalicylic acid—IKBKB—Immune System—KIR3DL1—ankylosing spondylitis	8.81e-05	0.00127	CbGpPWpGaD
Acetylsalicylic acid—Arthralgia—Prednisone—ankylosing spondylitis	8.7e-05	0.00289	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Triamcinolone—ankylosing spondylitis	8.7e-05	0.00289	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	8.68e-05	0.00289	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—CD79A—ankylosing spondylitis	8.68e-05	0.00125	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	8.67e-05	0.00125	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—B3GNT2—ankylosing spondylitis	8.55e-05	0.00123	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Prednisolone—ankylosing spondylitis	8.46e-05	0.00281	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Betamethasone—ankylosing spondylitis	8.43e-05	0.0028	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Dexamethasone—ankylosing spondylitis	8.43e-05	0.0028	CcSEcCtD
Acetylsalicylic acid—Urticaria—Triamcinolone—ankylosing spondylitis	8.39e-05	0.00279	CcSEcCtD
Acetylsalicylic acid—Urticaria—Methylprednisolone—ankylosing spondylitis	8.37e-05	0.00278	CcSEcCtD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	8.37e-05	0.00121	CbGpPWpGaD
Acetylsalicylic acid—Anaphylactic shock—Prednisone—ankylosing spondylitis	8.34e-05	0.00277	CcSEcCtD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—ERAP1—ankylosing spondylitis	8.34e-05	0.0012	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	8.29e-05	0.0012	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—CD79A—ankylosing spondylitis	8.22e-05	0.00119	CbGpPWpGaD
Acetylsalicylic acid—Shock—Prednisone—ankylosing spondylitis	8.21e-05	0.00273	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisone—ankylosing spondylitis	8.14e-05	0.00271	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisone—ankylosing spondylitis	8.07e-05	0.00268	CcSEcCtD
Acetylsalicylic acid—IKBKB—Innate Immune System—CARD9—ankylosing spondylitis	7.94e-05	0.00115	CbGpPWpGaD
Acetylsalicylic acid—Anaemia—Methotrexate—ankylosing spondylitis	7.9e-05	0.00263	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Betamethasone—ankylosing spondylitis	7.9e-05	0.00262	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dexamethasone—ankylosing spondylitis	7.9e-05	0.00262	CcSEcCtD
Acetylsalicylic acid—ALB—Folate Metabolism—CRP—ankylosing spondylitis	7.81e-05	0.00113	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	7.81e-05	0.00113	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Triamcinolone—ankylosing spondylitis	7.78e-05	0.00259	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	7.76e-05	0.00258	CcSEcCtD
Acetylsalicylic acid—IKBKB—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	7.74e-05	0.00112	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	7.73e-05	0.00112	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	7.72e-05	0.00111	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	7.68e-05	0.00111	CbGpPWpGaD
Acetylsalicylic acid—Vertigo—Methotrexate—ankylosing spondylitis	7.68e-05	0.00255	CcSEcCtD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—CRP—ankylosing spondylitis	7.67e-05	0.00111	CbGpPWpGaD
Acetylsalicylic acid—Leukopenia—Methotrexate—ankylosing spondylitis	7.65e-05	0.00254	CcSEcCtD
Acetylsalicylic acid—Urticaria—Betamethasone—ankylosing spondylitis	7.61e-05	0.00253	CcSEcCtD
Acetylsalicylic acid—Urticaria—Dexamethasone—ankylosing spondylitis	7.61e-05	0.00253	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisolone—ankylosing spondylitis	7.59e-05	0.00252	CcSEcCtD
Acetylsalicylic acid—TP53—Apoptosis—TNF—ankylosing spondylitis	7.51e-05	0.00108	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Triamcinolone—ankylosing spondylitis	7.47e-05	0.00248	CcSEcCtD
Acetylsalicylic acid—Pruritus—Methylprednisolone—ankylosing spondylitis	7.45e-05	0.00248	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methotrexate—ankylosing spondylitis	7.4e-05	0.00246	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Prednisone—ankylosing spondylitis	7.35e-05	0.00244	CcSEcCtD
Acetylsalicylic acid—Chest pain—Methotrexate—ankylosing spondylitis	7.27e-05	0.00242	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methotrexate—ankylosing spondylitis	7.27e-05	0.00242	CcSEcCtD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IL1A—ankylosing spondylitis	7.25e-05	0.00105	CbGpPWpGaD
Acetylsalicylic acid—Rash—Prednisolone—ankylosing spondylitis	7.24e-05	0.00241	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisolone—ankylosing spondylitis	7.23e-05	0.0024	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Methylprednisolone—ankylosing spondylitis	7.21e-05	0.0024	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—IL1A—ankylosing spondylitis	7.12e-05	0.00103	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	7.09e-05	0.00102	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—CD40LG—ankylosing spondylitis	7.07e-05	0.00102	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	7.05e-05	0.00102	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	7.05e-05	0.00102	CbGpPWpGaD
Acetylsalicylic acid—TP53—MAPK Signaling Pathway—TNF—ankylosing spondylitis	7.04e-05	0.00102	CbGpPWpGaD
Acetylsalicylic acid—Confusional state—Methotrexate—ankylosing spondylitis	7.03e-05	0.00234	CcSEcCtD
Acetylsalicylic acid—Dizziness—Triamcinolone—ankylosing spondylitis	6.98e-05	0.00232	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methotrexate—ankylosing spondylitis	6.97e-05	0.00232	CcSEcCtD
Acetylsalicylic acid—Dizziness—Methylprednisolone—ankylosing spondylitis	6.97e-05	0.00232	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisone—ankylosing spondylitis	6.88e-05	0.00229	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Methotrexate—ankylosing spondylitis	6.83e-05	0.00227	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisolone—ankylosing spondylitis	6.82e-05	0.00227	CcSEcCtD
Acetylsalicylic acid—Pruritus—Dexamethasone—ankylosing spondylitis	6.78e-05	0.00225	CcSEcCtD
Acetylsalicylic acid—Pruritus—Betamethasone—ankylosing spondylitis	6.78e-05	0.00225	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methotrexate—ankylosing spondylitis	6.74e-05	0.00224	CcSEcCtD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	6.73e-05	0.000972	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HLA-B—ankylosing spondylitis	6.73e-05	0.000971	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Triamcinolone—ankylosing spondylitis	6.71e-05	0.00223	CcSEcCtD
Acetylsalicylic acid—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	6.7e-05	0.000968	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Methylprednisolone—ankylosing spondylitis	6.7e-05	0.00223	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—CD40LG—ankylosing spondylitis	6.7e-05	0.000967	CbGpPWpGaD
Acetylsalicylic acid—Rash—Triamcinolone—ankylosing spondylitis	6.66e-05	0.00221	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Triamcinolone—ankylosing spondylitis	6.65e-05	0.00221	CcSEcCtD
Acetylsalicylic acid—Rash—Methylprednisolone—ankylosing spondylitis	6.64e-05	0.00221	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methylprednisolone—ankylosing spondylitis	6.64e-05	0.00221	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HLA-B—ankylosing spondylitis	6.64e-05	0.000958	CbGpPWpGaD
Acetylsalicylic acid—Urticaria—Prednisone—ankylosing spondylitis	6.63e-05	0.0022	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Betamethasone—ankylosing spondylitis	6.56e-05	0.00218	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Dexamethasone—ankylosing spondylitis	6.56e-05	0.00218	CcSEcCtD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—PTGER4—ankylosing spondylitis	6.54e-05	0.000944	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-C—ankylosing spondylitis	6.54e-05	0.000944	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	6.43e-05	0.000928	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HLA-B—ankylosing spondylitis	6.37e-05	0.00092	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MAPK Signaling Pathway—TNF—ankylosing spondylitis	6.37e-05	0.000919	CbGpPWpGaD
Acetylsalicylic acid—TP53—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	6.36e-05	0.000918	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Dexamethasone—ankylosing spondylitis	6.34e-05	0.00211	CcSEcCtD
Acetylsalicylic acid—Dizziness—Betamethasone—ankylosing spondylitis	6.34e-05	0.00211	CcSEcCtD
Acetylsalicylic acid—Nausea—Triamcinolone—ankylosing spondylitis	6.27e-05	0.00208	CcSEcCtD
Acetylsalicylic acid—Nausea—Methylprednisolone—ankylosing spondylitis	6.26e-05	0.00208	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—HLA-A—ankylosing spondylitis	6.23e-05	0.0009	CbGpPWpGaD
Acetylsalicylic acid—Dyspnoea—Methotrexate—ankylosing spondylitis	6.22e-05	0.00207	CcSEcCtD
Acetylsalicylic acid—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	6.21e-05	0.000897	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—CRP—ankylosing spondylitis	6.2e-05	0.000896	CbGpPWpGaD
Acetylsalicylic acid—Somnolence—Methotrexate—ankylosing spondylitis	6.2e-05	0.00206	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Prednisone—ankylosing spondylitis	6.15e-05	0.00204	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methotrexate—ankylosing spondylitis	6.14e-05	0.00204	CcSEcCtD
Acetylsalicylic acid—Vomiting—Betamethasone—ankylosing spondylitis	6.09e-05	0.00202	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dexamethasone—ankylosing spondylitis	6.09e-05	0.00202	CcSEcCtD
Acetylsalicylic acid—Rash—Dexamethasone—ankylosing spondylitis	6.04e-05	0.00201	CcSEcCtD
Acetylsalicylic acid—Rash—Betamethasone—ankylosing spondylitis	6.04e-05	0.00201	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Dexamethasone—ankylosing spondylitis	6.04e-05	0.00201	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Betamethasone—ankylosing spondylitis	6.04e-05	0.00201	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—CRP—ankylosing spondylitis	5.95e-05	0.000859	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.94e-05	0.000857	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.94e-05	0.000857	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HLA-B—ankylosing spondylitis	5.93e-05	0.000856	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HLA-A—ankylosing spondylitis	5.9e-05	0.000852	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Prednisone—ankylosing spondylitis	5.9e-05	0.00196	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—CRP—ankylosing spondylitis	5.87e-05	0.000847	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-C—ankylosing spondylitis	5.84e-05	0.000843	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	5.83e-05	0.000842	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TLR4—ankylosing spondylitis	5.81e-05	0.000839	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Methotrexate—ankylosing spondylitis	5.75e-05	0.00191	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Prednisone—ankylosing spondylitis	5.71e-05	0.0019	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—TLR4—ankylosing spondylitis	5.7e-05	0.000823	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Betamethasone—ankylosing spondylitis	5.69e-05	0.00189	CcSEcCtD
Acetylsalicylic acid—Nausea—Dexamethasone—ankylosing spondylitis	5.69e-05	0.00189	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—IL1RN—ankylosing spondylitis	5.68e-05	0.00082	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—TLR4—ankylosing spondylitis	5.62e-05	0.000812	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	5.56e-05	0.000803	CbGpPWpGaD
Acetylsalicylic acid—Urticaria—Methotrexate—ankylosing spondylitis	5.54e-05	0.00184	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisone—ankylosing spondylitis	5.52e-05	0.00183	CcSEcCtD
Acetylsalicylic acid—IKBKB—Apoptosis—TNF—ankylosing spondylitis	5.51e-05	0.000796	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	5.51e-05	0.000796	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	5.46e-05	0.000788	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1R2—ankylosing spondylitis	5.34e-05	0.00077	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Prednisone—ankylosing spondylitis	5.31e-05	0.00176	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisone—ankylosing spondylitis	5.26e-05	0.00175	CcSEcCtD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	5.26e-05	0.000759	CbGpPWpGaD
Acetylsalicylic acid—Dermatitis—Prednisone—ankylosing spondylitis	5.26e-05	0.00175	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—CRP—ankylosing spondylitis	5.24e-05	0.000757	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Methotrexate—ankylosing spondylitis	5.14e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	5.13e-05	0.00074	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL1RN—ankylosing spondylitis	5.07e-05	0.000733	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERAP1—ankylosing spondylitis	5.06e-05	0.00073	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—TLR4—ankylosing spondylitis	5.03e-05	0.000726	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HLA-C—ankylosing spondylitis	4.99e-05	0.00072	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD79A—ankylosing spondylitis	4.98e-05	0.00072	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Prednisone—ankylosing spondylitis	4.96e-05	0.00165	CcSEcCtD
Acetylsalicylic acid—Pruritus—Methotrexate—ankylosing spondylitis	4.93e-05	0.00164	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—PTGER4—ankylosing spondylitis	4.9e-05	0.000708	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	4.87e-05	0.000704	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-C—ankylosing spondylitis	4.79e-05	0.000692	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Methotrexate—ankylosing spondylitis	4.77e-05	0.00159	CcSEcCtD
Acetylsalicylic acid—IKBKB—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	4.72e-05	0.000682	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CARD9—ankylosing spondylitis	4.63e-05	0.000668	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Methotrexate—ankylosing spondylitis	4.61e-05	0.00153	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Immune System—CD79A—ankylosing spondylitis	4.46e-05	0.000643	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Methotrexate—ankylosing spondylitis	4.43e-05	0.00147	CcSEcCtD
Acetylsalicylic acid—Rash—Methotrexate—ankylosing spondylitis	4.4e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methotrexate—ankylosing spondylitis	4.39e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—PTGS1—Selenium Micronutrient Network—TNF—ankylosing spondylitis	4.37e-05	0.000631	CbGpPWpGaD
Acetylsalicylic acid—ALB—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	4.34e-05	0.000627	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—MMP3—ankylosing spondylitis	4.23e-05	0.00061	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—MMP3—ankylosing spondylitis	4.23e-05	0.00061	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Methotrexate—ankylosing spondylitis	4.14e-05	0.00138	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Disease—HLA-A—ankylosing spondylitis	4.13e-05	0.000596	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL1A—ankylosing spondylitis	4.09e-05	0.00059	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD40LG—ankylosing spondylitis	4.06e-05	0.000587	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ANTXR2—ankylosing spondylitis	4.03e-05	0.000581	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PTGER4—ankylosing spondylitis	3.92e-05	0.000567	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PTGER4—ankylosing spondylitis	3.88e-05	0.00056	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-B—ankylosing spondylitis	3.86e-05	0.000558	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	3.69e-05	0.000532	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD79A—ankylosing spondylitis	3.65e-05	0.000527	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL1A—ankylosing spondylitis	3.65e-05	0.000527	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD40LG—ankylosing spondylitis	3.63e-05	0.000524	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-A—ankylosing spondylitis	3.58e-05	0.000517	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—TNF—ankylosing spondylitis	3.53e-05	0.00051	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PTGER4—ankylosing spondylitis	3.51e-05	0.000506	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PTGER4—ankylosing spondylitis	3.51e-05	0.000506	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MMP3—ankylosing spondylitis	3.49e-05	0.000504	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—TNF—ankylosing spondylitis	3.47e-05	0.000501	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-B—ankylosing spondylitis	3.45e-05	0.000499	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CRP—ankylosing spondylitis	3.42e-05	0.000493	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—TLR4—ankylosing spondylitis	3.28e-05	0.000473	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-A—ankylosing spondylitis	3.2e-05	0.000462	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TNF—ankylosing spondylitis	3.17e-05	0.000457	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CRP—ankylosing spondylitis	3.05e-05	0.000441	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD40LG—ankylosing spondylitis	2.98e-05	0.00043	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HLA-B—ankylosing spondylitis	2.95e-05	0.000426	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—TLR4—ankylosing spondylitis	2.93e-05	0.000423	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-C—ankylosing spondylitis	2.91e-05	0.000419	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-B—ankylosing spondylitis	2.83e-05	0.000409	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—TNF—ankylosing spondylitis	2.81e-05	0.000405	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MMP3—ankylosing spondylitis	2.79e-05	0.000403	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MMP3—ankylosing spondylitis	2.76e-05	0.000399	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TNF—ankylosing spondylitis	2.74e-05	0.000396	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—TNF—ankylosing spondylitis	2.69e-05	0.000388	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	2.68e-05	0.000387	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-A—ankylosing spondylitis	2.62e-05	0.000379	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CRP—ankylosing spondylitis	2.61e-05	0.000376	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1RN—ankylosing spondylitis	2.52e-05	0.000364	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—B3GNT2—ankylosing spondylitis	2.5e-05	0.000361	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—TLR4—ankylosing spondylitis	2.5e-05	0.000361	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MMP3—ankylosing spondylitis	2.5e-05	0.000361	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MMP3—ankylosing spondylitis	2.5e-05	0.000361	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—B3GNT2—ankylosing spondylitis	2.37e-05	0.000343	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD79A—ankylosing spondylitis	2.22e-05	0.00032	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—B3GNT2—ankylosing spondylitis	1.99e-05	0.000287	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.87e-05	0.00027	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1A—ankylosing spondylitis	1.82e-05	0.000262	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD40LG—ankylosing spondylitis	1.81e-05	0.000261	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTGER4—ankylosing spondylitis	1.74e-05	0.000252	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-B—ankylosing spondylitis	1.72e-05	0.000248	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	1.62e-05	0.000233	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—B3GNT2—ankylosing spondylitis	1.61e-05	0.000232	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-A—ankylosing spondylitis	1.59e-05	0.00023	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CRP—ankylosing spondylitis	1.52e-05	0.000219	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TLR4—ankylosing spondylitis	1.46e-05	0.00021	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—B3GNT2—ankylosing spondylitis	1.44e-05	0.000208	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	1.41e-05	0.000203	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.32e-05	0.000191	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	1.32e-05	0.00019	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP3—ankylosing spondylitis	1.24e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HLA-A—ankylosing spondylitis	9.6e-06	0.000139	CbGpPWpGaD
